Sharkey RM, Karacay H, Cardillo TM, et al. Imp roving the delivery of radionuclides for imaging and therapy of cancer using p retargeting methods[J]. Clin Cancer Res , 2005, 11（S）: 7 109-7 121.
Mel Ton RG, Wibl In CN, Foster RL, et al. Covalent linkage of carboxypeptidase G2 to soluble dextrans: properties of conjugates and effect s on plasma persistence in mice[J]. Biochem Pharm, 1987, 36: 105-112.
[4]
Anthony LB, Woltering EA, Espanan GD, et al. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies[J]. Seminars Nucl Med, 2002, 32: 123-132.
[5]
Manabe Y, Tsubota T, Haruta Y, et al. Production of a monoclonal antibodymethotrexate conjugate utilizing dextran T-40 and its biologic activity[J]. J Lab Clin Med, 1984, 104: 445-454.
[6]
Behe M, Du J, Becker W, et al. Biodist ribution, blood half-life and receptor binding of a somatostatin dextran conjugate[J]. Medical Oncology, 2001, 18: 59-64.
[7]
Wulbrand U, Feldman M, Pfestroffa, et al. A novel somatostatin conjugates with a high affinity to all five somatostatin receptor subtypes [J]. Cancer, 2002, 94 (S4 ): 1 293-1 297.
Joensuu TK, Nilsson S, Holmberg AR, et al. Phase Ⅰ trial on Sms-D70 somatostatin analogue in advanced prostate and renal cell cancer [J ]. Ann N Y Acad Sci, 2004, 1 028: 361-374.
Liepe K, Runge R, Kotzerke J. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain[J]. J Cancer Res Clin Oncol, 2005, 31(1): 60-66.
[13]
Ando A, Ando I, Tonami N, et al. 177Lu-EDTMP: a potential therapeutic bone agent[J]. Nucl Med Commun, 1998, 19(6): 587-591.
[14]
Jansen DR, Krijger GC, Kolar ZI. Targeted radiotherapy of bone malignancies[J]. Curr Drug Discov Technol, 2010, 7(4): 233-246.
[15]
Seregni E, Maccauro M, Coliva A, et al. Treatment with tandem [(90)Y]DOTA-TATE and [(177)Lu] DOTA-TATE of neuroendocrine tumors refractory to conventional therapy: preliminary results[J]. Q J Nucl Med Mol Imaging, 2010, 54(1): 84-91.
[16]
O’Brien R, Gottlieb-Rosenkrantz P. An automatic method for viability assay of cultured cells[J]. J Histochem Cytochem, 1970，18(8): 581-589.
[17]
Du J, Hiltunen M, Marquez M, et al. Technetium-99m labelling of glycosylated somatostatin14[J]. Appl Radiat Isot, 2001, 55: 181-187.
[18]
Troy A, Scott JR. Determination of dextran with anthrone[J]. Anal Chem, 1953, 25 : 1 656-1 661.
Suneela S, Dhaneshwar, Mini Kandpal, et al. Dextran: a promising macromolecular drug carrier[J]. Indian Journal of Pharmaceutical Sciences, 2006, 11-12: 705-714.
[22]
Goodwin DA, Meares CF. Pretargeted peptide imaging and therapy[J]. Cancer Biother Radiopharm, 1999, 14: 145-152.
